Is DMCD or JNJ a better dividend investment in 2026?

DMCD currently yields 1000000.00% with a 5% 5-year dividend growth rate. JNJ yields 2.14% with 5.8% growth. The better choice depends on your goal: DMCD offers higher current income.

What is the dividend yield difference between DMCD and JNJ?

DMCD has a forward dividend yield of 1000000.00% ($2.00/share annually). JNJ yields 2.14% ($5.20/share annually). The yield gap is 999997.86 percentage points.

Home › Compare › DMCD vs JNJ

DMCD vs JNJ: Dividend Comparison 2026

DMCD yields 1000000.00% · JNJ yields 2.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DMCD wins by $4.7683925249533696e+36M in total portfolio value

INVESTMENT

TIME HORIZON10 years

DMCD

● Live price

1000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.7683925249533696e+36M

Annual income

$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00

Full DMCD calculator →

JNJ

Johnson & Johnson

● Live price

2.14%

Share price

$242.49

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.5K

Annual income

$4,749.88

Full JNJ calculator →

Portfolio growth — DMCD vs JNJ

📍 DMCD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	DMCD	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, DMCD + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

DMCD pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DMCD

Annual income on $10K today (after 15% tax)

$85,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$182.28/yr

After 10yr DRIP, annual income (after tax)

$4,037.40/yr

At 15% tax rate, DMCD beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DMCD + JNJ for your $10,000?

DMCD: 50%JNJ: 50%

100% JNJ50/50100% DMCD

Portfolio after 10yr

$2.3841962624766848e+36M

Annual income

$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.98%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DMCD

No analyst data

Altman Z

3.1

Piotroski

6/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-5.7% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DMCD buys

JNJ buys

No recent congressional trades found for DMCD or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricDMCDJNJ

Forward yield	1000000.00% ✓	2.14%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$4.7683925249533696e+36M	$30.5K ✓
Annual income after 10y	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓	$4,749.88
Total dividends collected	$4.7683311610149396e+36M	$15.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: DMCD vs JNJ ($10,000, DRIP)

Year	DMCD Portfolio	DMCD Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$100,010,700	$100,000,000.00	$10,594	$274.49	+$100.00M → DMCD
2	$934,786,450,701	$934,679,439,252.34	$11,294	$360.69	+$934786.44M → DMCD
3	$8,165,787,108,578,292	$8,164,786,887,076,042.00	$12,133	$476.91	+$8165787108.57M → DMCD
4	$66,665,884,190,957,650,000	$66,657,146,798,751,470,000.00	$13,156	$635.42	+$66665884190957.63M → DMCD
5	$508,662,171,058,048,100,000,000	$508,590,838,561,963,700,000,000.00	$14,432	$854.61	+$508662171058048128.00M → DMCD
6	$3,627,235,248,428,489,700,000,000,000	$3,626,690,979,905,457,600,000,000,000.00	$16,056	$1,162.76	+$3.62723524842849e+21M → DMCD
7	$24,173,681,159,150,610,000,000,000,000,000	$24,169,800,017,434,790,000,000,000,000,000.00	$18,175	$1,604.53	+$2.417368115915061e+25M → DMCD
8	$150,567,402,861,454,640,000,000,000,000,000,000	$150,541,537,022,614,370,000,000,000,000,000,000.00	$21,009	$2,252.68	+$1.5056740286145463e+29M → DMCD
9	$876,477,100,281,847,600,000,000,000,000,000,000,000	$876,315,993,160,785,800,000,000,000,000,000,000,000.00	$24,911	$3,229.73	+$8.764771002818475e+32M → DMCD
10	$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00	$30,458	$4,749.88	+$4.7683925249533696e+36M → DMCD

DMCD vs JNJ: Complete Analysis 2026

DMCD — Stock

Detwiler Fenton Group, Inc., through its subsidiaries, provides financial services to institutional and individual investors primarily in the United States. The company offers institutional channel research and wealth management/investment brokerage services to high net worth and other individuals. It also markets annuities and life insurance, health insurance, and long term care products, as well as mutual funds. The company, formerly known as Detwiler, Mitchell & Co., was founded in 1983 and is based in Boston, Massachusetts.

Full DMCD Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this DMCD vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DMCD vs SCHD DMCD vs JEPI DMCD vs O DMCD vs KO DMCD vs MAIN DMCD vs ABBV DMCD vs MRK DMCD vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.